Naltrexone Hydrochloride (TAGI Pharma Inc.)
Welcome to the PulseAid listing for the Naltrexone Hydrochloride drug offered from TAGI Pharma Inc.. This Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | TAGI Pharma Inc. |
NON-PROPRIETARY NAME: | Naltrexone Hydrochloride |
SUBSTANCE NAME: | NALTREXONE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-09-23 |
END MARKETING DATE: | 0000-00-00 |
Naltrexone Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Naltrexone Hydrochloride from TAGI Pharma Inc. |
LABELER NAME: | TAGI Pharma Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2013-09-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51224-206_c01fef04-5201-4a2a-be9f-59955c45d1dc |
PRODUCT NDC: | 51224-206 |
APPLICATION NUMBER: | ANDA075274 |
Other NALTREXONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: